Kenter G G, Cornelisse C J, Aartsen E J, Mooy W, Hermans J, Heintz A P, Fleuren G J
Department of Gynaecology, University of Leiden.
Gynecol Oncol. 1990 Nov;39(2):181-5. doi: 10.1016/0090-8258(90)90429-o.
Flow cytometry was used to measure DNA content of tumor cells in paraffin-embedded archival material from 89 patients with squamous cell carcinoma of the cervix uteri stages IB and IIA. Patients were all treated with radical hysterectomy and transperitoneal lymphadenectomy. Twenty-four percent received radiotherapy postoperatively because of tumor spread into parametria or positive lymph nodes. Ploidy grade was compared to other prognostic factors. DNA-aneuploidy was seen in 44 (49%), DNA-diploidy in 16 (18%) and 29 (33%) of the tumors were DNA-periploid. Sixty-nine (78%) patients were in FIGO stage IB, 20 (22%) in IIA. In 19 (21%) lymph node metastases were found, vasoinvasion in 25 (28%). Overall disease-specific 5-year survival was 80%. There was a significant effect of positive lymph nodes (90% vs 47%) and vasoinvasion (87% vs 64%) on the 5-year survival (resp. P less than 0.01 and P = 0.02). No correlation was found between stage (81% for IB vs 80% for IIA) or DNA-ploidy grade (81% for aneuploidy, 82% for periploidy, 79% for diploidy) and survival (resp. P = 0.9 and P = 0.8). Ploidy grade was equally divided over other prognostic factors. In stepwise Cox regression analysis DNA-ploidy grade showed no independent effect on survival. We conclude that DNA flow cytometry in this material was of no additional prognostic value.
采用流式细胞术检测89例子宫颈鳞状细胞癌IB期和IIA期患者石蜡包埋存档材料中肿瘤细胞的DNA含量。所有患者均接受根治性子宫切除术和经腹淋巴结清扫术。24%的患者因肿瘤扩散至宫旁组织或淋巴结阳性而在术后接受放疗。将倍体分级与其他预后因素进行比较。44例(49%)肿瘤呈现DNA非整倍体,16例(18%)为DNA二倍体,29例(33%)为DNA近倍体。69例(78%)患者处于国际妇产科联盟(FIGO)IB期,20例(22%)处于IIA期。19例(21%)发现有淋巴结转移,25例(28%)有血管侵犯。总体疾病特异性5年生存率为80%。淋巴结阳性(90%对47%)和血管侵犯(87%对64%)对5年生存率有显著影响(分别为P<0.01和P = 0.02)。未发现分期(IB期为81%对IIA期为80%)或DNA倍体分级(非整倍体为81%,近倍体为82%,二倍体为79%)与生存率之间存在相关性(分别为P = 0.9和P = 0.8)。倍体分级在其他预后因素中分布均匀。在逐步Cox回归分析中,DNA倍体分级对生存率无独立影响。我们得出结论,该材料中的DNA流式细胞术没有额外的预后价值。